---
title: "LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292381827.md"
description: "LifeSci Capital analyst Cory Jubinville maintained a Buy rating on Prime Medicine (PRME) with a $6.00 price target. Meanwhile, TipRanks launched the RANK ETF tracking its US Momentum Analysts Index. Other analysts' views include H.C. Wainwright issuing a Buy and Morgan Stanley maintaining a Hold on PRME."
datetime: "2026-07-11T14:35:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292381827.md)
  - [en](https://longbridge.com/en/news/292381827.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292381827.md)
---

# LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)

LifeSci Capital analyst Cory Jubinville, PhD maintained a Buy rating on Prime Medicine, Inc. today and set a price target of $6.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Jubinville, PhD is ranked #511 out of 12332 analysts.

In addition to LifeSci Capital, Prime Medicine, Inc. also received a Buy from H.C. Wainwright’s Arthur He CFA in a report issued on July 9. However, on July 8, Morgan Stanley maintained a Hold rating on Prime Medicine, Inc. (NASDAQ: PRME).

### Related Stocks

- [PRME.US](https://longbridge.com/en/quote/PRME.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Roth MKM Reaffirms Their Buy Rating on Trulite (TRUL)](https://longbridge.com/en/news/293045966.md)
- [Prime Medicine says FDA clears IND for PM577a in Wilson disease trial](https://longbridge.com/en/news/293661316.md)
- [Macquarie Keeps Their Buy Rating on Ryman Healthcare (RHCGF)](https://longbridge.com/en/news/292848387.md)
- [Goldman Sachs Keeps Their Hold Rating on Royal UNIBREW A/S (0R6Z)](https://longbridge.com/en/news/292727718.md)
- [Goldman Sachs Reaffirms Their Buy Rating on Raia Drogasil S.A. (RADL3)](https://longbridge.com/en/news/292522968.md)